Literature DB >> 35441324

Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.

Karl Bass1, Mohammad A M Momin2, Connor Howe1, Ghali Aladwani1, Sarah Strickler1, Arun V Kolanjiyil1, Michael Hindle2, Robert M DiBlasi3, Worth Longest4.   

Abstract

The objective of this study was to characterize the effects of multiple nasal prong interface configurations on nasal depositional loss of pharmaceutical aerosols in a preterm infant nose-throat (NT) airway model. Benchmark in vitro experiments were performed in which a spray-dried powder formulation was delivered to a new preterm NT model with a positive-pressure infant air-jet dry powder inhaler using single- and dual-prong interfaces. These results were used to develop and validate a computational fluid dynamics (CFD) model of aerosol transport and deposition in the NT geometry. The validated CFD model was then used to explore the NT depositional characteristic of multiple prong types and configurations. The CFD model highlighted a turbulent jet effect emanating from the prong(s). Analysis of NT aerosol deposition efficiency curves for a characteristic particle size and delivery flowrate (3 µm and 1.4 L/min (LPM)) revealed little difference in NT aerosol deposition fraction (DF) across the prong insertion depths of 2-5 mm (DF = 16-24%) with the exception of a single prong with 5-mm insertion (DF = 36%). Dual prongs provided a modest reduction in deposition vs. a single aerosol delivery prong at the same flow for insertion depths < 5 mm. The presence of the prongs increased nasal depositional loss by absolute differences in the range of 20-70% compared with existing correlations for ambient aerosols. In conclusion, the use of nasal prongs was shown to have a significant impact on infant NT aerosol depositional loss prompting the need for prong design alterations to improve lung delivery efficiency.
© 2022. The Author(s).

Entities:  

Keywords:  active DPI; high dose DPI; infant DPI; inline DPI; nose-to-lung aerosol delivery; rapid aerosol administration; trans-nasal aerosol delivery

Mesh:

Substances:

Year:  2022        PMID: 35441324     DOI: 10.1208/s12249-022-02259-z

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  38 in total

1.  An open label, pilot study of Aerosurf® combined with nCPAP to prevent RDS in preterm neonates.

Authors:  Neil N Finer; T Allen Merritt; Graham Bernstein; Leela Job; Jan Mazela; Robert Segal
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-10       Impact factor: 2.849

2.  Nasal high flow nebulization in infants and toddlers: An in vitro and in vivo scintigraphic study.

Authors:  François Réminiac; Laurent Vecellio; Ronan Mac Loughlin; Deborah Le Pennec; Maria Cabrera; Nathalie Heuzé Vourc'h; James B Fink; Stephan Ehrmann
Journal:  Pediatr Pulmonol       Date:  2016-07-08

3.  Aerosol delivery through nasal cannulas: an in vitro study.

Authors:  Abhiram R Bhashyam; Matthew T Wolf; Amy L Marcinkowski; Al Saville; Kristina Thomas; Joseph A Carcillo; Timothy E Corcoran
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-06       Impact factor: 2.849

4.  Deposition studies of aerosol delivery by nasal cannula to infants.

Authors:  Timothy E Corcoran; Al Saville; Phillip S Adams; Darragh J Johnston; Michael R Czachowski; Yuliya A Domnina; Jiuann-Huey Lin; Daniel J Weiner; Alex S Huber; Joan Sanchez De Toledo; Cecilia W Lo
Journal:  Pediatr Pulmonol       Date:  2019-04-01

5.  A novel continuous powder aerosolizer (CPA) for inhalative administration of highly concentrated recombinant surfactant protein-C (rSP-C) surfactant to preterm neonates.

Authors:  G Pohlmann; P Iwatschenko; W Koch; H Windt; M Rast; M Gama de Abreu; F J H Taut; C De Muynck
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-02-19       Impact factor: 2.849

Review 6.  Delivery of inhaled drugs for infants and small children: a commentary on present and future needs.

Authors:  James B Fink
Journal:  Clin Ther       Date:  2012-11       Impact factor: 3.393

Review 7.  Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy.

Authors:  Arzu Ari; James B Fink
Journal:  Expert Rev Respir Med       Date:  2011-08       Impact factor: 3.772

8.  Comparison of HFNC, bubble CPAP and SiPAP on aerosol delivery in neonates: An in-vitro study.

Authors:  Fatemah S Sunbul; James B Fink; Robert Harwood; Meryl M Sheard; Ralph D Zimmerman; Arzu Ari
Journal:  Pediatr Pulmonol       Date:  2014-12-09

9.  From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.

Authors:  F Bianco; F Ricci; C Catozzi; X Murgia; M Schlun; A Bucholski; U Hetzer; S Bonelli; M Lombardini; E Pasini; M Nutini; M Pertile; S Minocchieri; M Simonato; B Rosa; G Pieraccini; G Moneti; L Lorenzini; S Catinella; G Villetti; M Civelli; B Pioselli; P Cogo; V Carnielli; C Dani; F Salomone
Journal:  Respir Res       Date:  2019-07-02

10.  Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.

Authors:  Connor Howe; Michael Hindle; Serena Bonasera; Vijaya Rani; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-08-04       Impact factor: 2.849

View more
  1 in total

Review 1.  Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome.

Authors:  Frans J Walther; Alan J Waring
Journal:  Front Pediatr       Date:  2022-06-15       Impact factor: 3.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.